Celldex Therapeutics
CLDX
#4652
Rank
NZ$4.09 B
Marketcap
NZ$52.18
Share price
1.05%
Change (1 day)
24.31%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2026 (TTM): -NZ$0.57 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are NZ$0.15 Million. In 2025 the company made an earning of -NZ$0.53 Billion a decrease over its 2024 earnings that were of -NZ$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.57 Billion8.87%
2025 -NZ$0.53 Billion47.31%
2024 -NZ$0.36 Billion37.34%
2023 -NZ$0.26 Billion32.63%
2022 -NZ$0.2 Billion54.88%
2021 -NZ$0.13 Billion39.49%
2020 -NZ$89.73 Million-9.08%
2019 -NZ$98.69 Million-28.64%
2018 -NZ$0.14 Billion-30.11%
2017 -NZ$0.2 Billion-17.75%
2016 -NZ$0.25 Billion4.5%
2015 -NZ$0.24 Billion4.09%
2014 -NZ$0.23 Billion51.57%
2013 -NZ$0.15 Billion40.1%
2012 -NZ$0.11 Billion
2010 -NZ$2.26 Million-96.59%
2009 -NZ$66.25 Million
2006 -NZ$40.49 Million
2004 -NZ$24.59 Million15.75%
2003 -NZ$21.24 Million-18.69%
2002 -NZ$26.13 Million-41.22%
2001 -NZ$44.44 Million59%
2000 -NZ$27.95 Million27.65%
1999 -NZ$21.9 Million53.12%
1998 -NZ$14.3 Million2.6%
1997 -NZ$13.94 Million-33.62%
1996 -NZ$21 Million-1.69%
1995 -NZ$21.36 Million22.92%
1994 -NZ$17.38 Million-0%
1993 -NZ$17.38 Million
1991 -NZ$10.68 Million90.32%
1990 -NZ$5.62 Million10.71%
1989 -NZ$5.07 Million833.33%
1988 -NZ$0.55 Million-400%
1987 NZ$0.18 M-125%
1986 -NZ$0.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.61 B-2,238.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.00 B-3,491.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$12.94 B-2,295.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-NZ$5.08 Million-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.44 Billion 142.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.27 B-146.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.36 Billion-40.28%๐Ÿ‡บ๐Ÿ‡ธ USA